Michael Schmidt

Stock Analyst at Guggenheim

(0)
# 4191
Out of 5,291 analysts
131
Total ratings
35.71%
Success rate
-9.48%
Average return
Main Sectors:
Top Industries:
49 Stocks
Name Action Price Target Current % Upside Ratings Updated
Merus
Reiterates: Buy
109 109
44.52 144.83% 5 Mar 28, 2025
Adaptimmune Therapeu...
Maintains: Buy
3 2
0.21 733.33% 3 Mar 26, 2025
Verastem
Maintains: Strong Buy
13 14
6.2 125.81% 3 Mar 24, 2025
Immunome
Maintains: Buy
35 25
6.97 258.68% 2 Mar 20, 2025
Incyte
Downgrades: Neutral
92 92
60.59 51.84% 5 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
57 32
7.61 320.5% 4 Mar 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 1 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
18.95 137.47% 1 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 5 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
1.99 503.02% 1 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
42 42
36.7 14.44% 8 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 1 Jan 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
80 78
47.41 64.52% 1 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
1.49 571.14% 3 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
4.61 333.84% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
82 87
37.35 132.93% 2 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 8
1.81 341.99% 3 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
3.61 232.41% 1 Aug 28, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7
0.37 1791.89% 2 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
350 345
n/a n/a 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 31
n/a n/a 1 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 34
11.21 203.3% 4 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
40 42
13.17 218.91% 2 Jul 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
104 60
n/a n/a 10 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20
0.83 2309.64% 3 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
170
n/a n/a 3 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
1.52 1544.74% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
5.09 489.39% 1 Jul 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
1.85 1305.41% 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 39
n/a n/a 1 Apr 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 27, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 48
n/a n/a 2 Dec 11, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 5, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
80
30.28 164.2% 4 Feb 15, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 4 Jan 17, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
30
n/a n/a 2 Sep 25, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Outperform
24
n/a n/a 3 Sep 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
56 87
n/a n/a 4 Jan 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
4 6
3.5 57.14% 2 Nov 7, 2017